Senate Commerce Committee Statement to Senate, No. 3388 — State of New Jersey (February 10, 2025)

Summary

A Senate Commerce Committee statement to the Senate on Senate Bill No. 3388, State of New Jersey, dated February 10, 2025, reporting the bill favorably. The bill allows a pharmacist to transfer a Schedule II controlled dangerous substance prescription for attention-deficit/hyperactivity disorder to another pharmacist, in compliance with federal regulations. The statement says federal rules now allow one-time transfers of Schedule II-V prescriptions for initial filling at the patient's request, while New Jersey allows transfers only for Schedule III-V. It says the change helps patients filling prescriptions for medicine that is less available due to a shortage, who now must ask a health care provider for a new prescription.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SENATE COMMERCE COMMITTEE

STATEMENT TO

SENATE, No.
3388

STATE
OF NEW JERSEY

DATED: FEBRUARY
10, 2025

The Senate Commerce Committee reports favorably Senate
Bill No. 3388.

This
bill allows pharmacists to transfer Schedule II controlled dangerous substance
prescriptions for attention-deficit/hyperactivity disorder to other
pharmacists.

Specifically,
the bill provides that a Schedule II controlled dangerous substance that is
prescribed for attention-deficit/hyperactivity disorder may be transferred from
a pharmacist to another pharmacist, provided the prescription transfer is in
compliance with federal regulations.

Federal
rules recently changed to allow the transfer of Schedule II-V controlled
dangerous substance prescriptions between licensed pharmacies for the initial
filling on a one-time basis only, upon request from the patient. New Jersey
currently allows for transfers of Schedule III-V controlled dangerous substance
prescriptions; this bill would expand allowable transfers to also include
Schedule II controlled dangerous substance prescriptions.

The
bill will allow for greater flexibility for people attempting to fill
attention-deficit/hyperactivity disorder prescriptions. The ability to easily
transfer prescriptions between pharmacies is especially valuable to patients
who are attempting to fill prescriptions for medicine that is less available
due to a shortage. Currently, when a patient is unable to fill a prescription
at a particular pharmacy, the patient must ask their health care provider to
send a new prescription to a different pharmacy. The bill will allow for a
more efficient transfer process, by allowing pharmacies to directly transfer
attention-deficit/hyperactivity disorder prescriptions.

File and source

File

2025-02-10_SCM_S3388_S1.htm

Size

6,136 bytes

SHA-256

57d1eeabeb887184d755a6adbdcbff3c84ce5693d9e1eaad93d0d636887575ed

Our copy

2025-02-10_SCM_S3388_S1.htm

Original

No public link identified.